Acadia Pharma (ACAD) NUPLAZID NDA Accepted for Review; 05/01/16 PDUFA Date Set

Go back to Acadia Pharma (ACAD) NUPLAZID NDA Accepted for Review; 05/01/16 PDUFA Date Set
Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) Delayed: 22.11 +0.58 (2.69%)
Previous Close $21.53    52 Week High $42.49 
Open $21.50    52 Week Low $16.64 
Day High $22.13    P/E N/A 
Day Low $21.03    EPS $-0.42 
Volume 1,201,527